G. Randy Smith Jr

G. Randy Smith Jr

Auto-generated profile, based on publicly available information

G. Randy Smith Jr

Division of Hospital Medicine, Department of Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AMAmanda S. Mixon
Amanda S. Mixon
GJG. Randy Smith Jr
G. Randy Smith Jr
MMMeghan Mallouk
Meghan Mallouk
HNHarry Reyes Nieva
Harry Reyes Nieva
SKSunil Kripalani
Sunil Kripalani
JSJeffrey L. Schnipper
Jeffrey L. Schnipper
Background: The first Multi-center Medication Reconciliation Quality Improvement Study (MARQUIS1) demonstrated that implementation of a medication reconciliation best practices toolkit decreased total unintentional medication discrepancies in five hospitals. We sought to implement the MARQUIS toolkit in more diverse hospitals, incorporating lessons learned from MARQUIS1.Methods: MARQUIS2 is a pragmatic, mentored implementation QI study which collected clinical and implementation outcomes. Sites implemented a revised toolkit, which included interventions from these domains: 1) best possible medication history (BPMH)-taking; 2) discharge medication reconciliation and patient/caregiver counseling; 3) identifying and defining clinician roles and responsibilities; 4) risk stratification; 5) health information technology improvements; 6) improved access to medication sources; 7) identification and correction of real-time discrepancies; and, 8) stakeholder engagement. Eight hospitalists mentored the sites via one site visit and monthly phone calls over the 18-month intervention period. Each site’s local QI team assessed opportunities to improve, implemented at least one of the 17 toolkit components, and accessed a variety of resources (e.g. implementation manual, webinars, and workshops). Outcomes to be assessed will include unintentional medication discrepancies per patient.Discussion: A mentored multi-center medication reconciliation QI initiative using a best practices toolkit was successfully implemented across 18 medical centers. The 18 participating sites varied in size, teaching status, location, and electronic health record (EHR) platform.We introduce barriers to implementation and lessons learned from MARQUIS1, such as the importance of utilizing dedicated, trained medication history takers, simple EHR solutions, clarifying roles and responsibilities, and the input of patients and families when improving medication reconciliation.

26 June 2021 in Pain Medicine
Verified
Journal Article
Closed access
PDF file
GSG Randy Smith
G Randy Smith
SRSridevi Ramalingam
Sridevi Ramalingam
SZShuhan Zhou
Shuhan Zhou
CYChen Yeh
Chen Yeh
JLJungwha Lee
Jungwha Lee
KOKevin J O’Leary
Kevin J O’Leary
Objective: To determine the efficacy of a program to limit the use of the intravenous (IV) push route for opioids on the experience of pain by inpatients and on associated safety events. Design: Retrospective cohort study. Setting: Two inpatient general medicine floor units at an urban tertiary care academic medical center. Subjects: 4,752 inpatient opioid recipients. Methods: Patients in one unit were exposed to a multidisciplinary intervention to limit the prescription of opioids via the IV push route, with the other unit used as a control unit. The primary study outcome was the mean numeric pain score per patient during the hospital stay. Secondary measures included the hospital length of stay and postdischarge patient satisfaction. Fidelity measures included the percentage of the patient population exposed to each opioid administration route and the amount of opioid administered per route. Safety measures included patient disposition, transfer to intensive care, and incidence of naloxone administration. Results: The intervention was successful in decreasing both the percentage of patients exposed to IV push opioids and the amount of opioid administered via the IV push route, but no associated changes in other study outcomes were identified. Conclusions: For the treatment of acute pain in medical inpatients, no evidence of benefit or harm was identified in relation to an increase or decrease in the use of the IV push opioid route.